Unveiling 14 Analyst Insights On Axsome Therapeutics
Unveiling 14 Analyst Insights On Axsome Therapeutics
揭示了关于axsome therapeutics的14个分析师见解
Across the recent three months, 14 analysts have shared their insights on Axsome Therapeutics (NASDAQ:AXSM), expressing a variety of opinions spanning from bullish to bearish.
在最近的三个月中，有14位分析师分享了他们对axsome therapeutics (纳斯达克: AXSM) 的见解，表达了从看好到看淡的各种观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
In the assessment of 12-month price targets, analysts unveil insights for Axsome Therapeutics, presenting an average target of $132.14, a high estimate of $190.00, and a low estimate of $95.00. A decline of 0.18% from the prior average price target is evident in the current average.
营业收入增长：axsome therapeutics在3个月内取得了积极的成果。截至2024年6月30日，该公司实现了约86.65%的可观营业收入增长率。这表明公司的营业收入大幅增加。与同行业相比，该公司的增长率高于医疗保健板块同行业的平均水平。
Exploring Analyst Ratings: An In...
分析师评级...
登录免费看全文
登录/注册